CeloNova BioSciences, Inc. is an innovative global medical device leader transforming the treatment of cardiovascular disease and promoting positive outcomes in patients around the world. CeloNova BioSciences develops, manufactures and markets a family of products based upon its novel Polyzene™-F nanocoating technology. This next-generation nanocoating is the result of years of rigorous scientific research and German-engineering, and has been widely published in numerous academic articles to date.
The COBRA PzF™ NanoCoated Coronary Stent (NCS) is CeloNova BioSciences’ latest generation stent featuring the nano-thin Polyzene-F coating. The COBRA PzF stent’s unique properties allow physicians to safely and effectively treat their patients who may benefit from a minimum duration of 1-month DAPT therapy per ACC/AHA guidelines. IMPORTANT SAFETY INFORMATION http://celonova.com/cobra-pzf-nanocoated-stent/precautions/
Location: France, Ile-de-France, Rueil-Malmaison
Employees: 51-200
Phone: +1 888-388-3888
Founded date: 2000
Investors 2
| Date | Name | Website |
| - | SWK Holdin... | swkhold.co... |
| - | WP Global ... | wpglobalpa... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 01.03.2017 | Newly approved cardiac stent may provide alternative for som... | There is a concern that cardiac stents are overused. In fact, a study published in the Journal of t... | medcitynew... |
| - | Newly approved cardiac stent may provide alternative for som... | There is a concern that cardiac stents are overused. In fact, a study published in the Journal of t... | medcitynew... |